Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence Clinical Trials in Guangzhou, China/Guangdong

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer